These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 32023)

  • 41. LB-46 in angina pectoris. A critique of anti-anginal drug assessment.
    Ganeshan KP; Xavier KB
    Indian Heart J; 1972 Jun; 24():Suppl 1:197-20. PubMed ID: 4147275
    [No Abstract]   [Full Text] [Related]  

  • 42. A comparative study of three beta 1-adrenoreceptor blocking drugs with different degree of intrinsic stimulating activity (metoprolol, practolol and H 87/07) in patients with angina pectoris.
    Keyriläinen O; Uusitalo A
    Ann Clin Res; 1978 Aug; 10(4):185-90. PubMed ID: 30388
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment of stable angina pectoris with calcium antagonists and beta-blockers. The APSIS study. Angina Prognosis Study in Stockholm.
    Rehnqvist N; Hjemdahl P; Billing E; Björkander I; Eriksson SV; Forslund L; Held C; Näsman P; Wallén HN
    Cardiologia; 1995 Dec; 40(12 Suppl 1):301. PubMed ID: 8903053
    [No Abstract]   [Full Text] [Related]  

  • 44. Beta blockers 1984. Part 2.
    Wing LM
    Aust Fam Physician; 1984 Aug; 13(8):604, 606, 608. PubMed ID: 6149740
    [No Abstract]   [Full Text] [Related]  

  • 45. [Anti-angina therapy of coronary heart disease. Mono- or combination treatment].
    Kurz T; Rauch B; Kübler W
    Z Kardiol; 1991 May; 80(5):305-16. PubMed ID: 1678565
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Effectiveness of a new beta adrenergic blocking agent (penbutolol) in the treatment of ischemic cardiopathy].
    Ortuño Aznar F; Martín Jadraque L
    Med Clin (Barc); 1985 May; 84(19):766-8. PubMed ID: 2863437
    [No Abstract]   [Full Text] [Related]  

  • 47. [Respective role of beta-blockers and calcium inhibitors in the current treatment of angina pectoris].
    Metzger JP; Baubion N; Donne C; Bloch E; Dumas P; Vacheron A
    Sem Hop; 1982 Oct; 58(39):2263-5. PubMed ID: 6129705
    [No Abstract]   [Full Text] [Related]  

  • 48. [Role of beta-blockers in angina pectoris and myocardial infarction].
    Toyama S; Suzuki K
    Nihon Rinsho; 1982; 40(11):2439-43. PubMed ID: 6130170
    [No Abstract]   [Full Text] [Related]  

  • 49. [Why it is necessary to reduce heart rate in the treatment of stable angina?].
    Makolkin VI; Ziabrev FN
    Kardiologiia; 2006; 46(9):88-91. PubMed ID: 17047624
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of effects of propranolol and practolol on exercise tolerance in angina pectoris.
    Coltart DJ
    Br Heart J; 1971 Jan; 33(1):62-4. PubMed ID: 4395792
    [No Abstract]   [Full Text] [Related]  

  • 51. Heart rate reduction in the treatment of chronic stable angina pectoris: experiences with a sinus node inhibitor.
    Frishman WH; Gabor R; Pepine C; Cavusoglu E
    Am Heart J; 1996 Jan; 131(1):204-10. PubMed ID: 8554014
    [No Abstract]   [Full Text] [Related]  

  • 52. [Kinetic analysis of therapeutic doses of beta-blockers for angina pectoris based on receptor occupancy theory--relationship between beta 1-receptor occupancy or vasodilative action and dose].
    Yamada Y; Matsuyama K; Takayanagi R; Kotaki H; Sawada Y; Iga T
    Yakugaku Zasshi; 1999 Jul; 119(7):495-501. PubMed ID: 10434801
    [TBL] [Abstract][Full Text] [Related]  

  • 53. What you need to know about beta blockers. The blood pressure drugs may be prescribed if others haven't proved effective.
    Heart Advis; 2009 May; 12(5):6-7. PubMed ID: 20449868
    [No Abstract]   [Full Text] [Related]  

  • 54. Effect of beta-adrenergic blocker therapy on the circadian rhythm of heart rate variability in patients with chronic stable angina pectoris.
    Burger AJ; Kamalesh M
    Am J Cardiol; 1999 Feb; 83(4):596-8, A8. PubMed ID: 10073869
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Treatment of angina pectoris with beta blockaders can be optimized by isotope techniques].
    Boström PA; Lilja B; Johansson BW; Erhardt L
    Lakartidningen; 1992 Aug; 89(34):2653-5. PubMed ID: 1357238
    [No Abstract]   [Full Text] [Related]  

  • 56. Do partial agonist beta-blockers have improved clinical utility?
    Fitzgerald JD
    Cardiovasc Drugs Ther; 1993 Jun; 7(3):303-10. PubMed ID: 8103354
    [TBL] [Abstract][Full Text] [Related]  

  • 57. New arguments in favour of cardioselective beta-blockers.
    Cleophas TJ; Kalmansohn RB
    Neth J Med; 1995 Dec; 47(6):308-10. PubMed ID: 8569939
    [No Abstract]   [Full Text] [Related]  

  • 58. [Treatment of angina pectoris with beta-blocking agents].
    Puech P; Grolleau R
    Sem Hop Ther; 1974 Jan; 50(1):11-3. PubMed ID: 4152740
    [No Abstract]   [Full Text] [Related]  

  • 59. Beta-blocking agents.
    Opie LH
    Lancet; 1980 Aug; 2(8191):428-9. PubMed ID: 6105549
    [No Abstract]   [Full Text] [Related]  

  • 60. [Beta blockaders in different forms of angina pectoris].
    Groussin P
    Cardiology; 1978; 63 Suppl 1():30-1. PubMed ID: 28836
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.